title: Hormonal therapy in oncology: a primer for the radiologist.
abstract: OBJECTIVE
  The purpose of this article is to provide a comprehensive imaging review of the common hormonal therapies used in oncology and the side effects associated with them.
  
  
  CONCLUSIONS
  Commonly used hormones in oncology include corticosteroids, somatostatin analogues, progestins, gonadotropin-releasing hormone agonists and antagonists, antiandrogens, aromatase inhibitors, and selective estrogen receptor modulators. Familiarity with these hormones and their side effects can help radiologists to be vigilant for the side effects and complications of these agents.
authors.affiliation: 1 Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Fairchild
authors.forename: Sree Harsha
authors.initials: SH
authors.lastname: Tirumani
authors.forename: Michael H
authors.initials: MH
authors.lastname: Rosenthal
authors.forename: Stephanie A
authors.initials: SA
authors.lastname: Howard
authors.forename: Katherine M
authors.initials: KM
authors.lastname: Krajewski
authors.forename: Mizuki
authors.initials: M
authors.lastname: Nishino
authors.forename: Atul B
authors.initials: AB
authors.lastname: Shinagare
authors.forename: Jyothi P
authors.initials: JP
authors.lastname: Jagannathan
authors.forename: Nikhil H
authors.initials: NH
authors.lastname: Ramaiya
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D003952:Diagnostic Imaging / Q000379:methods*; D016903:Drug Monitoring / Q000379:methods*; D006727:Hormone Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D006728:Hormones / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis* / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D006727:Hormone Antagonists; D006728:Hormones
keywords: aromatase inhibitors; corticosteroids; hormonal therapy; imaging; somatostatin; tamoxifen